Position in REGN
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$40,311,861
-$5,215,951 QoQ
Shares Held
64,650
+9.7% QoQ
Ownership
0.063%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#142
of 1,322 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Derivatives in REGN
reported options exposure · as of Mar 31, 2025CallValue
$3,260
CallShares
200
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026HighTower Advisors, LLC holds $312,855,129 across 115 Biotechnology names. REGN ranks #2 (12.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INBX |
Inhibrx Biosciences, Inc.
|
870,551 | $82,484,707 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
64,650 | $40,311,861 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
105,045 | $31,621,696 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
49,020 | $24,349,704 | |
| 5 | RPRX |
Royalty Pharma plc
|
285,630 | $16,015,274 | |
| 6 | EXEL |
Exelixis, Inc.
|
291,162 | $15,842,124 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
56,313 | $13,783,733 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
140,394 | $11,443,514 |
All Filings in REGN
Export CSV
30 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $40,311,861 | 64,650 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $45,527,812 | 58,925 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $35,573,172 | 46,087 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $25,713,169 | 45,731 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $22,988,175 | 43,787 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $19,834,274 | 31,273 | Shares | Sole | 2025-05-13 | |
| 2025-03-31 | $3,260 | 200 | Call | Sole | 2025-05-13 | |
| 2024-12-31 | $21,585,023 | 30,302 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $34,717,201 | 33,025 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $6,710 | 200 | Call | Sole | 2024-08-13 | |
| 2024-06-30 | $37,181,237 | 35,376 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $32,890,208 | 34,172 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $30,372,146 | 34,581 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $28,957,493 | 35,187 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $24,695,501 | 34,369 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $21,049,542 | 25,618 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $22,191,589 | 30,758 | Shares | Sole | 2023-02-09 | |
| 2022-12-31 | $288,596 | 400 | Put | Sole | 2023-02-09 | |
| 2022-09-30 | $19,035,544 | 27,633 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $15,530,167 | 26,272 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $20,379,197 | 29,179 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $18,812,980 | 29,790 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $13,242,548 | 21,882 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $11,460,682 | 20,519 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $2,903,187 | 6,136 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $5,257,686 | 10,883 | Shares | Sole | 2021-02-10 | |
| 2020-12-31 | $483 | 1 | Put | Sole | 2021-02-10 | |
| 2020-09-30 | $5,790,924 | 10,345 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $7,160,749 | 11,482 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $5,825,787 | 11,931 | Shares | Sole | 2020-05-21 | |
| No filing history on record for this holder in this stock. | ||||||